As of May 27
| +0.06 / +1.79%|
The 1 analysts offering 12-month price forecasts for Clinuvel Pharmaceuticals Ltd have a median target of 3.24, with a high estimate of 3.24 and a low estimate of 3.24. The median estimate represents a -5.37% decrease from the last price of 3.42.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.